Search
  1. Home
  2. Africa
  • News

Hundreds of millions needed for HIV vaccine

    JOHANNESBURG

    Some US $233 million is needed to accelerate Africa's quest for an HIV vaccine, a forum in Cameroon on the African AIDS Vaccine Programme heard this week.

    At least 200 AIDS experts were in the capital, Yaounde, to review the status of HIV vaccine research and the challenges to the continent's active participation in this research.

    "A major scientific challenge for developing a safe and effective vaccine that will protect the African population is the extensive variety of HIV sub-types existing in Africa, including in Cameroon," said Dr Marie-Paule Kieny, the director for the World Health Organisation's Initiative for Vaccine Research.

    Five African countries are currently conducting phase I and phase II clinical trials of candidate HIV vaccines, and one large-scale phase III trial involving 16,000 volunteers is underway in Thailand.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join